Ceridian HCM Stock Forecast, Price & News

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ceridian HCM in the last twelve months. There are currently 5 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Ceridian HCM stock.
View analyst ratings for Ceridian HCM or view top-rated stocks.

Wall Street analysts have given Ceridian HCM a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Ceridian HCM wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Ceridian HCM is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Ceridian HCM.

Ceridian HCM Holding Inc. (NYSE:CDAY) issued its quarterly earnings results on Monday, February, 8th. The company reported $0.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.02. The business had revenue of $222.80 million for the quarter, compared to analysts' expectations of $217.96 million. Ceridian HCM had a positive trailing twelve-month return on equity of 0.02% and a negative net margin of 3.72%.
View Ceridian HCM's earnings history.

Ceridian HCM's stock was trading at $56.63 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CDAY shares have increased by 56.8% and is now trading at $88.81.
View which stocks have been most impacted by COVID-19.

Ceridian HCM issued an update on its second quarter 2021 earnings guidance on Wednesday, May, 26th. The company provided earnings per share guidance of - for the period. The company issued revenue guidance of $236 million-$240 million.

11 Wall Street analysts have issued 12 month price targets for Ceridian HCM's stock. Their forecasts range from $72.00 to $120.00. On average, they anticipate Ceridian HCM's stock price to reach $100.13 in the next year. This suggests a possible upside of 12.8% from the stock's current price.
View analysts' price targets for Ceridian HCM or view top-rated stocks among Wall Street analysts.

902 employees have rated Ceridian HCM CEO David Ossip on Glassdoor.com. David Ossip has an approval rating of 92% among Ceridian HCM's employees. This puts David Ossip in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Ceridian HCM include CrowdStrike (CRWD), DocuSign (DOCU), Roblox (RBLX), Palantir Technologies (PLTR), Veeva Systems (VEEV), Electronic Arts (EA), Synopsys (SNPS), UiPath (PATH), Cadence Design Systems (CDNS), Atlassian (TEAM), Datadog (DDOG), ANSYS (ANSS), Cloudflare (NET), Okta (OKTA) and Unity Software (U).
View all of CDAY's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceridian HCM investors own include Workday (WDAY), Advanced Micro Devices (AMD), Alibaba Group (BABA), NVIDIA (NVDA), Adobe (ADBE), Alteryx (AYX), Costco Wholesale (COST), ServiceNow (NOW), Paycom Software (PAYC) and Tesla (TSLA).

(CDAY) raised $420 million in an initial public offering on Thursday, April 26th 2018. The company issued 21,000,000 shares at $19.00-$21.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse and Deutsche Bank Securities acted as the underwriters for the IPO and Barclays, Citigroup, Jefferies, CIBC Capital Markets, Wells Fargo Securities, Baird, Canaccord Genuity, Piper Jaffray, William Blair and MUFG were co-managers.

Ceridian HCM trades on the New York Stock Exchange (NYSE) under the ticker symbol "CDAY."

Ceridian HCM's stock is owned by a number of institutional and retail investors. Top institutional investors include Price T Rowe Associates Inc. MD (13.61%), BlackRock Inc. (8.79%), Select Equity Group L.P. (4.84%), Janus Henderson Group PLC (3.98%), JPMorgan Chase & Co. (3.80%) and Bamco Inc. NY (2.01%). Company insiders that own Ceridian HCM stock include Arthur Gitajn, Cannae Holdings, Inc, Christopher R Armstrong, David D Ossip, Jeffrey Scott Jacobs, Leagh Erin Turner, Lisa M Sterling, Ozzie J Goldschmied, Scott A Kitching and Thomas H Lee Advisors, Llc.
View institutional ownership trends for Ceridian HCM.

CDAY stock was sold by a variety of institutional investors in the last quarter, including Artisan Partners Limited Partnership, Sei Investments Co., D. E. Shaw & Co. Inc., Allianz Asset Management GmbH, New York State Common Retirement Fund, Federated Hermes Inc., Royal Bank of Canada, and Comerica Bank. Company insiders that have sold Ceridian HCM company stock in the last year include Christopher R Armstrong, David D Ossip, Jeffrey Scott Jacobs, Leagh Erin Turner, Scott A Kitching, and Thomas H Lee Advisors, Llc.
View insider buying and selling activity for Ceridian HCM or view top insider-selling stocks.

CDAY stock was bought by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Contour Asset Management LLC, Select Equity Group L.P., BlackRock Inc., Goldman Sachs Group Inc., Janus Henderson Group PLC, Nishkama Capital LLC, and Fred Alger Management LLC.
View insider buying and selling activity for Ceridian HCM or or view top insider-buying stocks.

Shares of CDAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CDAY stock can currently be purchased for approximately $88.81.

Ceridian HCM has a market capitalization of $13.25 billion and generates $842.50 million in revenue each year. The company earns $-4,000,000.00 in net income (profit) each year or $0.14 on an earnings per share basis.

Ceridian HCM employs 5,974 workers across the globe.

The official website for Ceridian HCM is www.ceridian.com.

Ceridian HCM is headquartered at 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425.

Ceridian HCM's mailing address is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. The company can be reached via phone at 952-853-8100 or via email at [email protected]